Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Analysts made several notable moves across different sectors over the past 24 hours. Upgrades dominated in refining and managed care, while a high-profile cosmetics name took a hit.
Phillips 66 and Marathon Petroleum both received consensus target price increases. Marathon's average target rose to $409.28, up from $400. Refining margins have held up better than feared heading into the winter season.
Humana picked up an upgrade from the analyst community. The consensus shifted, with hold ratings rising from 11 to 10 and sell ratings trimmed. The average target jumped to $452.87 from $433.74. Managed care stocks have faced pressure from elevated medical costs, and some analysts now see the selloff as overdone.
Estee Lauder went the other way. Analysts cut their rating, adding to the sell pile. The consensus moved from 13 holds to 14 holds, with one fewer buy. The stock has struggled with weak demand in China and a slow recovery in travel retail.
Delta Air Lines got a target price lift to $101.65. That fits with the broader air travel picture: international passenger volumes have risen 10% year on year in markets like South Korea, per ORTEX Alt Data, pointing to continued demand outside the domestic corridor.
Axon Enterprise saw a modest target trim to $697.26 from $704.11. The stock trades at a high multiple and analysts are fine-tuning expectations after a strong run.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
